The University of Queensland

Knowledge leadership for a better world

Innovations

                            
                                    Published
                            
                Healthcare & Pharmaceuticals
            
The Future of Sleep Health
                UQ researchers have developed technology for measuring neuropsychological impairments using electroencephalography and other data acquired during standard sleep diagnostic tests.
            
By
                            The University of Queensland
                        
Reference Number  
                09907
            
Last Update  
                 Feb 09, 2023
            
                                    Published
                            
                Telecommunications
            
Orthogonal precoding
                Orthogonal precoding is a promising, linear technique in which the null space of a precoding matrix with orthonormal columns is designed to suppress the sidelobes.
            
By
                            The University of Queensland
                        
Reference Number  
                09881
            
Last Update  
                 Jan 31, 2023
            
                                    Published
                            
                Medical
            
Fluorescent bioassay for hGH
                University of Queensland researchers have developed a fluorescent in vitro cell-based bioassay capable of continuously detecting the potency of hGH using high content imaging
            
By
                            The University of Queensland
                        
Reference Number  
                09339
            
Last Update  
                 Oct 13, 2022
            
                                    Published
                            
                Sciences
            
Transgenic plants
                Using Agrobacterium-mediated transformation, University of Queensland (UQ) researchers have developed transgenic plants capable of producing cyclic peptides.
            
By
                            The University of Queensland
                        
Reference Number  
                09235
            
Last Update  
                 Sep 16, 2022
            
                                    Published
                            
                Healthcare & Pharmaceuticals
            
C3a Receptor Modulators
                University of Queensland researchers have developed series of novel, potent and selective, small organic molecules that mimic C3a (agonists) or inhibit its action (antagonists)
            
By
                            The University of Queensland
                        
Reference Number  
                09029
            
Last Update  
                 May 30, 2022
            
                                    Published
                            
                Manufacturing & Production
            
Yeast expression booster
                Technology for targeted and stable  integration of a gene in a manner that affords control of copy number and increased protein expression compared to standard yeast systems
            
By
                            The University of Queensland
                        
Reference Number  
                09027
            
Last Update  
                 May 27, 2022
            
                                    Published
                            
                Education & Training
            
YOLO
                A web-based, scalable psychological intervention, tailored specifically for mental health distress commonly experienced by university students.
            
By
                            The University of Queensland
                        
Reference Number  
                09024
            
Last Update  
                 May 25, 2022
            
                                    Published
                            
                Software & Platforms
            
iAx
                A simple and easy-to-use software that digitally collects patient responses to evidence-based questionnaires
            
By
                            The University of Queensland
                        
Reference Number  
                09003
            
Last Update  
                 May 25, 2022
            
                                    Published
                            
                Healthcare & Pharmaceuticals
            
Modulators of Class IIa HDACs
                UQ has exploited structural differences between Class I and IIa HDACs to develop two generations of new compounds that are potent and selective inhibitors of class IIa HDACs.
            
By
                            The University of Queensland
                        
Reference Number  
                08993
            
Last Update  
                 May 27, 2022
            
                                    Published
                            
                Healthcare & Pharmaceuticals
            
Vaccine for autoimmune disease
                Vaccination against viruses (eg EBV/CMV) could intercept progression of certain AI diseases. Clec9a-targeted liposomes (tailorable payloads) generate a robust CD141+ DC1 response.
            
By
                            The University of Queensland
                        
Reference Number  
                08988
            
Last Update  
                 May 06, 2022
            
                                    Published
                            
                Healthcare & Pharmaceuticals
            
IBD Therapeutic
                Novel class of NF-κβ inhibitory bioactives identified from gut bacteria and developed into molecules that alleviates colitis in a murine model of inflammatory bowel disease.
            
By
                            The University of Queensland
                        
Reference Number  
                08987
            
Last Update  
                 May 06, 2022
            
                                    Published
                            
                Healthcare & Pharmaceuticals
            
ACE2 Peptide Agonist for CKD
                ACE2 agonist with anti-fibrotic and anti-inflammatory activity, and that controls blood glucose levels in diabetic mouse models; potential to treat diabetic organ disease.
            
By
                            The University of Queensland
                        
Reference Number  
                08986
            
Last Update  
                 May 06, 2022